Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017

Migration is associated with HIV-1 vulnerability. Objectives: To identify long-term trends in HIV-1 molecular epidemiology and antiretroviral drug resistance (ARV) among migrants followed up in Portugal Methods: 5177 patients were included between 2001 and 2017. Rega, Scuel, Comet, and jPHMM algorithms were used for subtyping. Transmitted drug resistance (TDR) and Acquired drug resistance (ADR) were defined as the presence of surveillance drug resistance mutations (SDRMs) and as mutations of the IAS-USA 2015 algorithm, respectively. Statistical analyses were performed. Results: HIV-1 subtypes infecting migrants were consistent with the ones prevailing in their countries of origin. Over time, overall TDR significantly increased and specifically for Non-nucleoside reverse transcriptase inhibitor (NNRTIs) and Nucleoside reverse transcriptase inhibitor (NRTIs). TDR was higher in patients from Mozambique. Country of origin Mozambique and subtype B were independently associated with TDR. Overall, ADR significantly decreased over time and specifically for NRTIs and Protease Inhibitors (PIs). Age, subtype B, and viral load were independently associated with ADR. Conclusions: HIV-1 molecular epidemiology in migrants suggests high levels of connectivity with their country of origin. The increasing levels of TDR in migrants could indicate an increase also in their countries of origin, where more efficient surveillance should occur.

[1]  L. P. Coelho,et al.  Prevalence of HIV-1 transmitted drug resistance and viral suppression among recently diagnosed adults in São Paulo, Brazil , 2019, Archives of Virology.

[2]  Ibrahim Abubakar,et al.  Global patterns of mortality in international migrants: a systematic review and meta-analysis , 2018, The Lancet.

[3]  F. Månsson,et al.  Prevalence of HIV-1 pretreatment drug resistance among treatment naïve pregnant women in Bissau, Guinea Bissau , 2018, PloS one.

[4]  K. Pottie,et al.  The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review , 2018, International journal of environmental research and public health.

[5]  R. Shafer,et al.  Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Prosperi,et al.  The global burden of HIV-1 drug resistance in the past 20 years , 2018, PeerJ.

[7]  D. Pizzol,et al.  Health-care services for young people with HIV in Mozambique. , 2018, The Lancet. Child & adolescent health.

[8]  J. Albert,et al.  Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden , 2018, AIDS.

[9]  Ann Nowé,et al.  The impact of HIV-1 within-host evolution on transmission dynamics. , 2018, Current opinion in virology.

[10]  B. Brenner,et al.  Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings , 2017, Viruses.

[11]  Tulio de Oliveira,et al.  HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis , 2017, The Lancet. Infectious diseases.

[12]  N. Bannert,et al.  Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort , 2017, AIDS.

[13]  E. Maltezos,et al.  Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health , 2017, Genes.

[14]  Á. Holguín,et al.  Trends in Drug Resistance Prevalence, HIV-1 Variants and Clinical Status in HIV-1-infected Pediatric Population in Madrid: 1993 to 2015 Analysis , 2017, The Pediatric infectious disease journal.

[15]  J. Ussher,et al.  Refugee and migrant women's engagement with sexual and reproductive health care in Australia: A socio-ecological analysis of health care professional perspectives , 2017, PloS one.

[16]  R. Shafer,et al.  HIV-1 drug resistance and resistance testing. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  V. Veloso,et al.  Impact of HIV-1 Subtypes on AIDS Progression in a Brazilian Cohort. , 2016, AIDS research and human retroviruses.

[18]  R. Shafer,et al.  Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis , 2016, PloS one.

[19]  Programa Nacional para a Infeção Vih,et al.  Infeção VIH/SIDA: a situação em Portugal a 31 de dezembro de 2014 , 2015 .

[20]  A. Tanuri,et al.  Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique , 2015, PloS one.

[21]  K. Anderson,et al.  Current Perspectives on HIV-1 Antiretroviral Drug Resistance , 2014, Viruses.

[22]  H. Stellbrink,et al.  Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany , 2014, PloS one.

[23]  Glenn Lawyer,et al.  COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification , 2014, Nucleic acids research.

[24]  A. Marques,et al.  HIV Risky Sexual Behaviors and HIV Infection Among Immigrants: A Cross-Sectional Study in Lisbon, Portugal , 2014, International journal of environmental research and public health.

[25]  A. Vicente,et al.  Profile of the HIV Epidemic in Cape Verde: Molecular Epidemiology and Drug Resistance Mutations among HIV-1 and HIV-2 Infected Patients from Distinct Islands of the Archipelago , 2014, PloS one.

[26]  H. Günthard,et al.  Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Anne-Mieke Vandamme,et al.  Automated subtyping of HIV-1 genetic sequences for clinical and surveillance , 2013 .

[28]  A. Tanuri,et al.  Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique , 2013, PloS one.

[29]  Jean Ruelle,et al.  RegaDB: community-driven data management and analysis for infectious diseases , 2013, Bioinform..

[30]  G. Bello,et al.  HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola , 2012, PloS one.

[31]  F. Hamers,et al.  The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. , 2011, European journal of public health.

[32]  A. Tanuri,et al.  Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola. , 2010, AIDS research and human retroviruses.

[33]  A. Vandamme,et al.  Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[34]  Tulio de Oliveira,et al.  A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences , 2009, Nucleic Acids Res..

[35]  Anne-Mieke Vandamme,et al.  Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update , 2009, PloS one.

[36]  M. Peeters,et al.  Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries , 2008, Antiviral therapy.

[37]  G. Bello,et al.  Demographic history of HIV-1 subtypes B and F in Brazil. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[38]  Ming Zhang,et al.  jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1 , 2006, Nucleic Acids Res..

[39]  A. Vandamme,et al.  HIV-1 genetic variants circulation in the North of Angola. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[40]  Ester C Sabino,et al.  Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): a survey of chronically infected individuals , 2003, AIDS.

[41]  G. Learn,et al.  Distribution of HIV‐1 subtypes seen in an AIDS clinic in Sao Paulo City, Brazil , 1996, AIDS.

[42]  Ross J. Harris,et al.  Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK , 2017, The Journal of antimicrobial chemotherapy.

[43]  E. Arts,et al.  Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. , 2011, The Lancet. Infectious diseases.